ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

7 links0 made here, not in the record8 judgments1 judge (the rules as one: Rule based)1 record change seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07947121A Study of RisvutatugRezetecan in CombinationWith Atezolizumab inParticipants With ExtensiveStage Small Cell LungCancer (EMBOLD-SCLC-303)GlaxoSmithKlinePhase 3 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 18 · ClinicalTrials.gov record · Version of 2026-11-18Version of 2026-11-18CONDITIONSLung NeoplasmsThe registry's MeSH filing›Nov 18 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedSmall Cell Lung CarcinomaThe registry's MeSH filing›Nov 18 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionDRUGSRisvutatug rezetecanEntry “Ris-Rez”, read by our name rule›As of now · Rule based · BackgroundBackgroundAtezolizumabIntervention entry›As of now · Rule based · BackgroundBackgroundEtoposideIntervention entry›As of now · Rule based · ComparatorComparatorCarboplatinIntervention entry›As of now · Rule based · ComparatorComparatorPM 01183Entry “Lurbinectedin”, read by our na…›As of now · Rule based · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Lung Neoplasms

From the registry record1 judgment on this link
Kind of condition link, from the registry to what was judged
RegistryLung Neoplasms, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 18The record itselfClinicalTrials.gov recordVersion of 2026-11-18Record change
Nov 18Lung NeoplasmsRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 18Small Cell Lung CarcinomaRule based · condition-kind ruleFinest filed termCurrent
As of nowSmall Cell Lung CarcinomaRule based · main-condition ruleMain conditionCurrent
As of nowRisvutatug rezetecanRule based · role ruleBackgroundCurrent
As of nowAtezolizumabRule based · role ruleBackgroundCurrent
As of nowEtoposideRule based · role ruleComparatorCurrent
As of nowCarboplatinRule based · role ruleComparatorCurrent
As of nowPM 01183Rule based · role ruleComparatorCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.